Human ROR gamma/RORC/NR1F3 Antibody
R&D Systems, part of Bio-Techne | Catalog # PP-H6437-00
Key Product Details
Species Reactivity
Validated:
Human
Applications
Direct ELISA, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2A Clone # H6437
Product Summary for Human ROR gamma/RORC/NR1F3 Antibody
Immunogen
Recombinant human ROR gamma/RORC/NR1F3
Specificity
This antibody specifically recognizes human ROR gamma and does not cross-react with human ROR alpha or human ROR beta. Not yet tested in other species.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Human ROR gamma/RORC/NR1F3 Antibody
Application
Recommended Usage
Direct ELISA
This antibody can be used at 0.3 μg/mL with the appropriate secondary reagents to detect human ROR gamma.
Immunoprecipitation
Optimal dilutions should be determined by each laboratory.
Western Blot
This antibody can be used at 1 μg/mL under reducing conditions with the appropriate secondary reagents to detect human ROR gamma.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
A liquid formulation in physiologic saline with 0.1% NaN3.
Shipping
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
This antibody is stable for greater than six months when held at -20 °C in a manual defrost freezer or at -70 °C. Upon thawing, the antibody can be stored at 2-8 °C for at least 1 month without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Background: ROR gamma/RORC/NR1F3
Long Name
Retinoic Acid-Related Orphan Receptor gamma
Alternate Names
NR1F3, RORC, RZRG
Entrez Gene IDs
6097 (Human)
Gene Symbol
RORC
Additional ROR gamma/RORC/NR1F3 Products
Product Documents for Human ROR gamma/RORC/NR1F3 Antibody
Product Specific Notices for Human ROR gamma/RORC/NR1F3 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...